US20070044813A1 - Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy - Google Patents

Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy Download PDF

Info

Publication number
US20070044813A1
US20070044813A1 US11/508,265 US50826506A US2007044813A1 US 20070044813 A1 US20070044813 A1 US 20070044813A1 US 50826506 A US50826506 A US 50826506A US 2007044813 A1 US2007044813 A1 US 2007044813A1
Authority
US
United States
Prior art keywords
allergy
snuff
preparation
leaves
house dust
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/508,265
Inventor
Tanios Sleiman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of US20070044813A1 publication Critical patent/US20070044813A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Definitions

  • the present application relates to the use of an (aqueous) preparation derived from leaves of Nicotiana tabacum , in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff, for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy. It also relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy, said method including the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum , in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff.
  • House dust mite allergy and cigarette smoke allergy are characterised by one or more of the following symptoms: watering eyes, an itchy nose and palate, a stuffed up nose, snoring.
  • Such allergies are often treated with conventional medicament such as desloratadine and fexofenadine hydrochloride.
  • medicaments control the symptoms only partly and often cause alleviation of the symptoms of around 40%.
  • Snuff is a well-known stimulant that has been used for centuries.
  • a method for its preparation is as follows: After undergoing several maturation processes, the tobacco leave is ground to a silk-like powder. Then the powder is sieved to obtain an even and smooth powder. Users snuff this powder for a pleasant and stimulating experience.
  • the present invention relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
  • the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
  • the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy.
  • the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of cigarette smoke allergy.
  • one-teaspoon snuff was taken into 100 ml sterile water.
  • Sterile water may be obtained commercially or can simply be prepared, for example by boiling tap water.
  • the resultant was adminstered once a day, 3 drops per nostril, during 2 weeks. Using such preparation and administration regime, the intended result was achieved, and all of the above symptoms of house dust mite allergy and/or cigarette smoke allergy disappeared.
  • the aqueous preparation may be any aqueous preparation that is physiologically acceptably, and is preferably sterile.
  • sterile water was used to prepare the aqueous preparation.
  • Sterile saline solutions in particular physiological saline solutions, may also be used.
  • the aqueous preparation may comprise pharmaceutically acceptable auxiliaries, such as buffer, dispergants, and the like. The skilled practitioner will be aware of suitable aqueous preparations and auxiliaries.
  • the term “derived from leaves of Nicotiana tabacum ” refers to a product that is derived from leaves of Nicotiana tabacum .
  • the preparation may comprise a product that is obtained by extracting the leaves of the tobacco plant Nicotiana tabacum , gring of such leaves, or the like. Any product that can be incorporated in an aqueous preparation and can be administered intranasallly is suitable for incorporation in the aqueous preparation according to the present invention.
  • the preparation comprises a product chosen from the group consisting of tobacco extract, ground tobacco leaves and snuff.
  • tobacco extract ground tobacco leaves and snuff.
  • the effectivity of snuff has been demonstrated, and it is expected that the invention will similarly be applicable to preparations comprising tobacco extract and/or ground tobacco leaves.
  • the product is snuff, since snuff has been found to yield the intended result.
  • the aqueous product may, in particular in the case of snuff, be prepared just prior to it application by adding 1-10 grams, preferably 2-7 grams, more preferably 3-5 grams, to 50-150 ml, preferably about 75-125 ml, water or aqueous solution.
  • the aqueous preparation according to the present invention is administered during 1 week, preferably 2 weeks.
  • the administration regime is preferably once a day administration of the above aqueous preparation, 2-5, preferably about 3, drops a day.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy. The preparation may comprise tobacco extract, ground tobacco leaves or snuff. In a preferred embodiment, the aqueous preparation is a preparation of snuff dispersed in water or an aqueous solution.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • The present application claims the benefit of Netherlands application number 1029798 filed Aug. 24, 2005, the contents of which are incorporated by reference herein.
    • FIELD OF THE INVENTION
  • The present application relates to the use of an (aqueous) preparation derived from leaves of Nicotiana tabacum, in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff, for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy. It also relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy, said method including the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum, in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff.
    • BACKGROUND OF THE INVENTION
  • House dust mite allergy and cigarette smoke allergy are characterised by one or more of the following symptoms: watering eyes, an itchy nose and palate, a stuffed up nose, snoring.
  • Such allergies are often treated with conventional medicament such as desloratadine and fexofenadine hydrochloride. However, such medicaments control the symptoms only partly and often cause alleviation of the symptoms of around 40%.
    • SUMMARY OF THE INVENTION
  • It has now surprisingly been found that daily intranasal administration of an aqueous preparation of snuff during some time resulted in disappearance of the above symptoms. Once the symptoms had disappeared, the therapeutic treatment was stopped. Nevertheless the symptoms did not re-appear for at least one and a half-year, without revering to conventional therapy.
  • Snuff is a well-known stimulant that has been used for centuries. A method for its preparation is as follows: After undergoing several maturation processes, the tobacco leave is ground to a silk-like powder. Then the powder is sieved to obtain an even and smooth powder. Users snuff this powder for a pleasant and stimulating experience. A therapeutic use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy, in particular when the snuff is incorporated in an aqueous preparation, has hitherto not been described.
  • It is expected that the same effect on house dust mite allergy and/or cigarette smoke allergy as described for snuff will also be achieved using other (aqueous) preparations derived from leaves of Nicotiana tabacum, in particular tobacco extract and ground tobacco leaves. It is expected that the leaves comprise one or more substances that can serve as active ingredient in a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
  • Also, the present invention relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
    • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
  • In a preferred embodiment, the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy.
  • In another embodiment, the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of cigarette smoke allergy.
  • In the case of snuff, one-teaspoon snuff was taken into 100 ml sterile water. Sterile water may be obtained commercially or can simply be prepared, for example by boiling tap water. The resultant was adminstered once a day, 3 drops per nostril, during 2 weeks. Using such preparation and administration regime, the intended result was achieved, and all of the above symptoms of house dust mite allergy and/or cigarette smoke allergy disappeared.
  • The aqueous preparation may be any aqueous preparation that is physiologically acceptably, and is preferably sterile. In the present example, sterile water was used to prepare the aqueous preparation. Sterile saline solutions, in particular physiological saline solutions, may also be used. Further, the aqueous preparation may comprise pharmaceutically acceptable auxiliaries, such as buffer, dispergants, and the like. The skilled practitioner will be aware of suitable aqueous preparations and auxiliaries.
  • The term “derived from leaves of Nicotiana tabacum” refers to a product that is derived from leaves of Nicotiana tabacum. For example, the preparation may comprise a product that is obtained by extracting the leaves of the tobacco plant Nicotiana tabacum, gring of such leaves, or the like. Any product that can be incorporated in an aqueous preparation and can be administered intranasallly is suitable for incorporation in the aqueous preparation according to the present invention.
  • In a preferred embodiment, the preparation comprises a product chosen from the group consisting of tobacco extract, ground tobacco leaves and snuff. The effectivity of snuff has been demonstrated, and it is expected that the invention will similarly be applicable to preparations comprising tobacco extract and/or ground tobacco leaves.
  • In a more preferred embodiment the product is snuff, since snuff has been found to yield the intended result. The aqueous product may, in particular in the case of snuff, be prepared just prior to it application by adding 1-10 grams, preferably 2-7 grams, more preferably 3-5 grams, to 50-150 ml, preferably about 75-125 ml, water or aqueous solution.
  • Preferably, the aqueous preparation according to the present invention is administered during 1 week, preferably 2 weeks. The administration regime is preferably once a day administration of the above aqueous preparation, 2-5, preferably about 3, drops a day.

Claims (8)

1. The use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
2. The use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy.
3. Use according to claim 1, the preparation comprising a product chosen from the group consisting of tobacco extract, ground tobacco leaves and snuff.
4. Use according to claim 3, the product being snuff.
5. A method for treating house dust mite allergy and/or cigarette smoke allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
6. A method for treating house dust mite allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
7. Method according to claim 5, the preparation comprising a product chosen from the group consisting of tobacco extract, ground tobacco leaves, and snuff.
8. Method according to claim 7, the product being snuff.
US11/508,265 2005-08-24 2006-08-23 Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy Abandoned US20070044813A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1029798 2005-08-24
NL1029798A NL1029798C2 (en) 2005-08-24 2005-08-24 Application of snuff for the treatment of respiratory allergy.

Publications (1)

Publication Number Publication Date
US20070044813A1 true US20070044813A1 (en) 2007-03-01

Family

ID=37802338

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/508,265 Abandoned US20070044813A1 (en) 2005-08-24 2006-08-23 Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy

Country Status (2)

Country Link
US (1) US20070044813A1 (en)
NL (1) NL1029798C2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1839970A (en) * 1924-06-09 1932-01-05 Moorman Mfg Co Vermifuge medicine and process of producing same
US4261981A (en) * 1980-01-28 1981-04-14 Sam Humphrey Medical compound produced from ragweed
US4579858A (en) * 1983-01-21 1986-04-01 Aktiebolaget Leo Smoking substitutes for nasal administration-I

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1839970A (en) * 1924-06-09 1932-01-05 Moorman Mfg Co Vermifuge medicine and process of producing same
US4261981A (en) * 1980-01-28 1981-04-14 Sam Humphrey Medical compound produced from ragweed
US4579858A (en) * 1983-01-21 1986-04-01 Aktiebolaget Leo Smoking substitutes for nasal administration-I

Also Published As

Publication number Publication date
NL1029798C2 (en) 2007-02-27

Similar Documents

Publication Publication Date Title
US20060062835A1 (en) Multi-disciplinary nicotine craving reduction kit with potentiating homeopathic elements
Josling et al. Use of cellulose powder for the treatment of seasonal allergic rhinitis
AU2009266076A1 (en) Antiallergic marine biopolymers
US20050100513A1 (en) Homeopathic method and system for treating nicotine addiction
US9061052B2 (en) Aqueous extract of tobacco leaves, its uses in the treatment of dependence
US20060210482A1 (en) Chemical composition and method for cold and sinus relief
JP2009536183A5 (en)
US20070044813A1 (en) Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy
CA3014725C (en) Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
US9226944B2 (en) Herbal preparation for sleep apnea relief
CA2506962A1 (en) Synergistic combination comprising roflumilast and formoterol
NL1032360C2 (en) Aqueous snuff preparation for treating e.g. house dust mite allergy, has tobacco extract and ground tobacco leaves or snuff, where preparation is derived from leaves of Nicotiana tabacum
US20220132882A1 (en) Herbal Tea Products and Methods
US10966988B2 (en) Method for smoking cessation
EP2593119B1 (en) Polysaccharide polymer from the seeds of the tamarind tree for use in treating dry cough
TW202310855A (en) Treatment of covid-19 and other viral infections, bacterial infections, injuries, ards, or conditions that result in acute elevation of substance p levels causing pathological activation of the cytokine system using nitrous oxide or any of the inhaled anesthetics
CN116322733A (en) Phytotherapeutic compositions
RU2146942C1 (en) Method of treatment of tobacco smoking
KR20230046905A (en) Respiratory Disease Treatment
US20210220371A1 (en) Method for smoking cessation
JP2022104569A (en) Drug and infectious disease prevention sheet and mask
WO2019162959A1 (en) A medicinal formulation for treatment of cough, sore throat and throat infection
NZ787061A (en) Compositions and methods for treating nasal and paranasal mucosa diseases with
US8399031B1 (en) Compositions and methods for restoring pulmonary function
US20020088470A1 (en) Method and composition for reducing the tobacco consumption of a human while freshening the breath from tobacco odors

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION